Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)
重新评估头孢吡肟或哌拉西林/他唑巴坦在减少产ESBL肠杆菌尿路感染中碳青霉烯类药物使用方面的应用(REDUCE-UTI)
期刊:JACAntimicrobial Resistance
影响因子:3.7
doi:10.1093/jacamr/dlad021
Branton, Alexander C; Vu, Catherine H; Venugopalan, Veena; Santevecchi, Barbara A; Cherabuddi, Kartikeya; Ramphal, Reuben; Manohar, Tanvi; Desear, Kathryn E